Shefali Agarwal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shefali Agarwal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shefali Agarwal. Shefali Agarwal is Director in FATE THERAPEUTICS INC ($FATE) and Chief Medical Officer in Epizyme, Inc. ($EPZM).
Latest Insider Trading Transactions of Shefali Agarwal
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.21 | 969 | 10,862 | 104,341 | 105.3 K to 104.3 K (-0.92 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 11.02 | 141,135 | 1,555,308 | 141,135 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 29,583 | 0 | 105,310 | 75.7 K to 105.3 K (+39.07 %) |
| Jan 27 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.41 | 2,872 | 32,770 | 75,727 | 78.6 K to 75.7 K (-3.65 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 16.15 | 1,805 | 29,151 | 78,611 | 80.4 K to 78.6 K (-2.24 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 80,416 | 74.4 K to 80.4 K (+8.06 %) |
| Mar 26 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 15.28 | 1,243 | 18,993 | 71,991 | 73.2 K to 72 K (-1.70 %) |
| Mar 26 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 1,575 | 0 | 73,234 | 71.7 K to 73.2 K (+2.20 %) |
| Mar 26 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 15.28 | 1,243 | 18,993 | 71,991 | 73.2 K to 72 K (-1.70 %) |
| Mar 26 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 1,575 | 0 | 73,234 | 71.7 K to 73.2 K (+2.20 %) |
| Feb 05 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 21.39 | 61,834 | 1,322,629 | 61,834 | |
| Feb 05 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 12,856 | 0 | 71,659 | 58.8 K to 71.7 K (+21.86 %) |
| Jan 27 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 20.44 | 2,630 | 53,757 | 58,803 | 61.4 K to 58.8 K (-4.28 %) |
| Jan 27 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 24.64 | 1,843 | 45,412 | 61,433 | 63.3 K to 61.4 K (-2.91 %) |
| Jan 27 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 63,276 | 58.3 K to 63.3 K (+8.58 %) |
| Dec 06 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 16.61 | 34,978 | 580,985 | 34,978 | |
| Dec 06 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 22,577 | 0 | 58,276 | 35.7 K to 58.3 K (+63.24 %) |
| Jul 17 2019 | FATE | FATE THERAPEUTICS ... | Agarwal Shefali | Director | Option Exercise | A | 22.14 | 24,000 | 531,360 | 24,000 | |
| Jun 17 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.97 | 1,195 | 14,304 | 35,699 | 36.9 K to 35.7 K (-3.24 %) |
| Jun 14 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 4,000 | 0 | 36,894 | 32.9 K to 36.9 K (+12.16 %) |
| Jan 28 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 9.12 | 151,620 | 1,382,774 | 151,620 | |
| Jan 28 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 32,894 | 0 | 32,894 | 0 to 32.9 K |
| Jan 28 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 9.12 | 151,620 | 1,382,774 | 151,620 | |
| Jan 28 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 32,894 | 0 | 32,894 | 0 to 32.9 K |
| Jul 24 2018 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 13.35 | 170,000 | 2,269,500 | 170,000 |
Page: 1